Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
5
×
boston blog main
boston top stories
5
×
life sciences
national blog main
clinical trials
fda
deals
investing
medical device
national top stories
startups
venture capital
20/20 healthcare partners
480 biomedical
ally bridge group
amgen ventures
amyotrophic lateral sclerosis
anthony despasqua
arsenal medical
big data analytics
biofourmis
biotech ipos
biovotion
blackrock
bob langer
casdin capital
christian angermayer
chronic rhinosinusitis
chugai pharmaceutical
covid-19
diabetic nephropathy
dolby family ventures
drug delivery
dyne therapeutics
edbi
enclear therapies
eventide asset management
financing
What
raised
5
×
million
company
ipo
new
therapeutics
biotech
develop
developing
diseases
drug
genetic
medicines
raises
treat
analysis
analytics
associated
bio
biofourmis
bring
brings
companies
data
debut
device
devices
dialysis
digital
disease
disorders
drugs
dyne
dyne’s
employing
employs
enclear
globally
goldfinch
harmful
Language
unset
Current search:
raised
×
boston
×
" boston top stories "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device